Understanding Mustard Vesicants Distribution and Toxicity in the Eye Using In Vivo and In Silico Models

使用体内和计算机模型了解芥末糜烂剂在眼中的分布和毒性

基本信息

  • 批准号:
    10709188
  • 负责人:
  • 金额:
    $ 46.7万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2023
  • 资助国家:
    美国
  • 起止时间:
    2023-09-01 至 2026-08-31
  • 项目状态:
    未结题

项目摘要

Project Summary Mustard vesicating agent sulfur mustard (SM) is the most extensively used warfare agent in history and remains a potential agent of warfare and terrorism. Eye is the most sensitive organ to SM and its analog nitrogen mustard (NM) exposure, resulting in devastating biphasic injury called Mustard Gas Keratopathy. The dose- and time- related severity of symptoms and the mechanism of this biphasic injury involving damage to the most affected cornea and possibly to other ocular tissues is not well understood. In addition, the extent to which mustard vesicants distribute, transport, and persist in various tissues of the eye is largely unknown, which could further identify tissue specific toxicity effects, injury progression and repair process. Such studies could aid in the identification of effective treatment strategies to counter tissue specific acute and long-term ocular complications from mustard vesicants’ exposure, which are elusive. To address this knowledge gap, we will use a synergistic in vivo-in silico approach to determine mustard vesicant ocular distribution and the ensuing corneal injury and repair mechanisms. We will leverage CFD Research’s existing in silico rabbit ocular model that is currently being used to characterize the distribution related toxicity of various chemical threat agents. Using the published data, preliminary in silico modeling studies show that NM penetrates well beyond the cornea. We hypothesize that a synergistic novel in vivo-in silico approach will assist in understanding how mustard vesicants distribute in healthy eyes and the mechanism by which the ocular injury develops, persists, and recovers or reappears as long-term complications. To support this hypothesis, the proposed specific aims will first computationally model NM (SM surrogate used in laboratory settings) related ocular injury and then translate this to simulate SM exposure. Aim 1: Determine Ocular Distribution of Nitrogen Mustard for Various Exposure Scenarios. The computational model will be validated on NM toxicokinetic (TK) profiles from in vivo rabbit studies and then extrapolated within the experimentally tested range to obtain TK profiles for non-tested NM exposure scenarios. Aim 2: Identify Relevant Biomarkers, Mechanisms and Pathways of NM-Induced Corneal Injury Progression and Repair. The combination of time- and dose-dependent transcriptomics and biomarker evaluation, as well as the NM TK analysis proposed under Aim 1, may contribute to determine the pathological mechanisms underlying early and late corneal injury development, progression, and repair related to vesicant bi-phasic keratopathy. Aim 3: Translation of the In Silico NM Rabbit Ocular Model to Simulate SM Exposure. The preliminary evaluations could assess comparisons of in Silico SM corneal injury model with NM, and serve as a vital step for minor alterations or in designing animal studies for additional validation under future studies. A combination of in silico and in vivo studies could serve as a more efficient and potentially more insightful novel approach to evaluate tissue-specific toxicity mechanisms underlying the mustard vesicants’ ocular pathology, and to identify therapeutic strategies that can improve the clinical mustard keratopathy symptoms and enhance wound healing.
项目总结

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Carrie German其他文献

Carrie German的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Carrie German', 18)}}的其他基金

A synergistic in vitro-in silico model of the placental barrier for predicting fetal exposure and toxicity of xenobiotic compounds
胎盘屏障的协同体外计算机模拟模型,用于预测胎儿的外源化合物暴露和毒性
  • 批准号:
    10698740
  • 财政年份:
    2023
  • 资助金额:
    $ 46.7万
  • 项目类别:
Real-Time Quantitation of Transport Across Vascular-Tissue Interfaces in Organ-On-Chip Models Using In Situ Mass Spectrometry
使用原位质谱法实时定量器官芯片模型中跨血管组织界面的运输
  • 批准号:
    10394501
  • 财政年份:
    2022
  • 资助金额:
    $ 46.7万
  • 项目类别:
An in vitro model for screening penetration of ocular drug products
筛选眼科药品渗透的体外模型
  • 批准号:
    10546892
  • 财政年份:
    2022
  • 资助金额:
    $ 46.7万
  • 项目类别:
Computational Biology (Cobi) Tools as a Framework for Physiologically-Based Pharmacokinetic/Pharmacodynamic Model Extrapolation from Rabbit to Human for Ophthalmic Drug Products
计算生物学 (Cobi) 工具作为基于生理学的药代动力学/药效学模型外推从兔到人眼科药品的框架
  • 批准号:
    10166845
  • 财政年份:
    2020
  • 资助金额:
    $ 46.7万
  • 项目类别:
Computational Biology (Cobi) Tools as a Framework for Physiologically-Based Pharmacokinetic/Pharmacodynamic Model Extrapolation from Rabbit to Human for Ophthalmic Drug Products
计算生物学 (Cobi) 工具作为基于生理学的药代动力学/药效学模型外推从兔到人眼科药品的框架
  • 批准号:
    10461730
  • 财政年份:
    2020
  • 资助金额:
    $ 46.7万
  • 项目类别:
Computational Biology (Cobi) Tools as a Framework for Physiologically-Based Pharmacokinetic/Pharmacodynamic Model Extrapolation from Rabbit to Human for Ophthalmic Drug Products
计算生物学 (Cobi) 工具作为基于生理学的药代动力学/药效学模型外推从兔到人眼科药品的框架
  • 批准号:
    10116143
  • 财政年份:
    2020
  • 资助金额:
    $ 46.7万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 46.7万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 46.7万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 46.7万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 46.7万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 46.7万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 46.7万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 46.7万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 46.7万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 46.7万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 46.7万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了